business and networking opportunities in the psychedelic space. Day 2 (April 20): Will focus more on the spirituality side and explore the intersection of psychedelics, spirituality, cannabis ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for treatment-resistant depression, could serve to further bolster a space hit hard ...